Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platform Study of Genotyping Guided Precision Medicine for Rare Tumors in China

NCT04423185 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04423185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04423185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platform Study of Genotyping Guided Precision Medicine for Rare Tumors in China
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Phase 2
Overall status
Recruiting
Start date
August 15, 2020
Completion date
July 1, 2028
Enrollment
770 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rare tumor